In the process of preparing for pregnancy, understanding the knowledge related to genetic diseases is crucial, especially for prospective parents with a family history of genetic disorders. Some diseases are inherited through sex-linked genes, such as hemophilia, which is an X-linked genetic disorder. People with hemophilia have impaired blood clotting abilities, making them prone to spontaneous bleeding or prolonged bleeding after injuries. Males are more likely to inherit this disease because they only have one X chromosome, while females have two X chromosomes; if one is defective, the other can usually compensate. Therefore, prospective parents with a family history of hemophilia may face the risk of having a male child who could inherit the disease.
IVF-PGT has provided new options and hope for families like these. Through preimplantation genetic testing, doctors can analyze the gender and genes of embryos before transfer, helping prospective parents avoid diseases that are inherited through specific genders. This not only offers a safer reproductive option for families at risk of genetic diseases but also allows them to plan their future family life with greater certainty.
Mr. Li and his wife, Mrs. Wang, are one such family. Several of Mrs. Wang's relatives have hemophilia, and they have long been concerned that this genetic disease might affect their future children. To ensure their child’s health, Mr. Li and Mrs. Wang sought help from IVF USA. After detailed discussions with Dr. Nathan Zhang and his team, they understood the advantages of IVF-PGT and decided to use this technology to conceive a daughter, thereby avoiding the risk of having a male child who might inherit hemophilia.
At IVF USA, Mr. Li and Mrs. Wang’s embryos underwent rigorous genetic screening. Using PGT technology, doctors could precisely identify the gender of each embryo and determine whether it carried the gene mutation associated with hemophilia. Ultimately, they successfully selected a healthy female embryo for transfer, and Mrs. Wang became pregnant, eventually giving birth to a healthy daughter. Mr. Li and Mrs. Wang not only fulfilled their dream of having a healthy child but also successfully avoided passing on the genetic disease to the next generation.
However, not all families opt for IVF-PGT due to the risk of genetic diseases. Some families use this technology to fulfill their preferences for the gender of their children, particularly those who already have one child and wish for a balanced family with both a son and a daughter. The gender screening capability of IVF-PGT can meet this need.
Mr. Zhang and his wife, Mrs. Liu, already had a lively and adorable son, but they had always dreamed of having a daughter to complete their family. Since natural conception couldn’t guarantee the desired gender, they decided to use the IVF-PGT technology at IVF USA for gender selection. With the help of IVF USA, Mr. Zhang and Mrs. Liu successfully completed embryo screening and eventually selected a healthy female embryo for transfer. When the news of pregnancy came, the entire family was filled with anticipation, and soon after, they welcomed their lovely daughter, just as they had hoped.
Whether it's to avoid genetic diseases or to meet family expectations for the gender of their child, IVF-PGT provides prospective parents with more flexible and safer options. At IVF USA, Dr. Nathan Zhang and his team are committed to customizing the most suitable fertility solutions for each family. With advanced medical technology and personalized care, they help more families achieve their dreams of parenthood. If you're considering IVF as a way to start or expand your family, IVF USA will provide you with comprehensive support and services, ensuring that you welcome a healthy new life with safety and confidence.
